跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hepatitis B Immunoglobulin (Human) - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hepatitis B Immunoglobulin (Human)
Approved
STANDARD
Hepatitis B Immunoglobulin (Human)
Green Cross Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e04cbea033851b8c
Company
Green Cross Corporation
Type
Standard
Approval Details
Approval Id
e04cbea033851b8c
Drug Approval Philippines Name
Hepatitis B Immunoglobulin (Human)
Product Name
Hepatitis B Immunoglobulin (Human)
Registration Number
BR-334
Brand Name
Hepatitis B Immunoglobulin (Human)
Generic Name
Hepabig
Dosage Form
Solution For Injection
Dosage Strength
100 IU/0.5 mL
Manufacturer
Green Cross Corporation
Importer
Vizcarra Pharmaceutical, Inc.
Distributor
Vizcarra Pharmaceutical, Inc.
Company Detail Path
/organization/green-cross-corporation
Issuance Date
19 April 2022
Expiry Date
06 April 2027
Pharmacologic Category
Immunoglobulin
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e04cbea033851b8c
Type
Standard
Back to Philippines FDA Approvals